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Atrial fibrillation (AF) affects millions of people worldwide
and is associated with increased morbidity and mortality [1].
The incidence of AF is expected to rise with aging of the
population. Research over the past decades has identified a
multitude of pathophysiological processes contributing to the
initiation, maintenance, and progression of AF. Therefore,
a comprehensive understanding of AF pathophysiology is
needed to foster the development of improved diagnos-
tic, pharmacological, and nonpharmacological therapeutic
approaches to improve clinicalmanagement.The focus of this
special issue of this journal is to capturemost recent advances
in the study of AF with the aim of directing further research.
Conventional mechanisms linked to AF are diverse and
expertly reviewed in various manuscripts [2, 3]. However,
progression in the field of AF research may come from an
unconventional view-angle. For example, M. Miragoli and
A. V. Glukhov reviewed the role of myofibroblasts as novel
targets for cardiac arrhythmias with the aim of describing
and evaluating the implications of noncardiomyocyte view
in the context of AF. B. Weil and C. Ozcan discussed
the pathophysiological remodelling in AF in comparison
with that occurring in hibernating myocardium, attempting
to identify common molecular mechanisms and proposing
possible future therapeutic implications of this emerging
paradigm.
In addition, the issue also contains the study of F. Cac-
ciani and M. Zaniboni who used a computational approach
to study the source-sink relationship between the sinoa-
trial node and surrounding atrium in control conditions
and under different simulated chronotropic interventions.
The authors defined a safety-factor for pacemaker-to-atrial
action potential conduction and tested the effects of different
antiarrhythmic-like interventions. Analytical study of C.
Loardi et al. found that there is an association between
postoperative left atrium dimensions and “kick” restoring
and an influence of right atrium contraction on left ventricle
function in patients that underwent radiofrequency (Maze)
procedure. Their study also highlights the deleterious influ-
ence of arrhythmia “chronic state” on procedural success
and importance of the cardiac right side, an entity somehow
overlooked.
The initial presentation of undiagnosed AF is often a
stroke. Therefore, methods for early detection of AF are
highly demanded. In this special issue, M. D. Zink et al.
investigated whether heart beat cycle length measurement
assessed by a novel algorithm for a ballistocardiography
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(BCG) foil is feasible during sinus rhythm and AF. The
latter might offer new possibilities for noninvasive heart rate
and thereby AF monitoring. Another approach to detect
AF would be the use of biomarkers. P. J. Howlett et al.
summarized the available evidence for electrophysiological,
molecular, and morphological biomarkers to improve the
detection of paroxysmal AF with reference to the underlying
mechanisms for the conduction. F.-C. Su et al. performed
a meta-analysis to investigate whether serum level of high-
sensitivity C-reactive protein (hs-CRP), a protein produced
by the liver during infection, tissue injury, and chronic
inflammation, can predict the efficacy of AF treatment with
atorvastatin.
The coagulative state in patients with chronic AF is higher
than that in patients with sinus rhythm [4]. As a result,
the incidence of thromboembolism is significantly higher in
patients with AF [5] which makes the latter an important
risk factor of cerebral embolism. In this issue, F. Shamoun
et al. reviewed the new generation of anticoagulants, along
with their efficacy and safety data. Their study suggests
that the novel oral anticoagulants indeed can reduce the
relative incidence of stroke in patients with AF. Similarly,
A. Panisello-Tafalla et al. examined the effectiveness of the
use of oral anticoagulation medication, recommended by
national guidelines for stroke preventions. They suggest that
the low efficiency of oral anticoagulants results from the
association between their underuse and undiagnosedAF.The
treatment of platelet aggregation in patients with AF requires
a specific approach as highlighted by A. M. Martischnig et al.
who found that dabigatran as compared to phenprocoumon
had no impact on adenosine diphosphate (ADP) induced
platelet aggregation in AF patients neither with nor without
concomitant clopidogrel therapy.
The extensive work reviewed in this special issue high-
lights the enormous advances achieved in understanding
AF pathophysiology over the past 20 years and suggests an
importance of the mechanism-based approaches for ther-
apeutic breakthroughs. We believe that the future of AF
management will be determined by the application of new
scientific insights into the underlying mechanistic determi-
nants.
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